HUP0104520A2 - Szubsztituált benzo[de]izokinolin-1,3-dion-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények - Google Patents

Szubsztituált benzo[de]izokinolin-1,3-dion-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP0104520A2
HUP0104520A2 HU0104520A HUP0104520A HUP0104520A2 HU P0104520 A2 HUP0104520 A2 HU P0104520A2 HU 0104520 A HU0104520 A HU 0104520A HU P0104520 A HUP0104520 A HU P0104520A HU P0104520 A2 HUP0104520 A2 HU P0104520A2
Authority
HU
Hungary
Prior art keywords
group
compounds
diones
isoquinoline
preparation
Prior art date
Application number
HU0104520A
Other languages
English (en)
Inventor
Gerhard Barnickel
Sabine Bernotat-Danielowski
Ralf Devant
Daljit Dhanoa
Todd Graybill
Werner Mederski
Guido Melzer
Peter Raddatz
James Rinker
Richard Soll
Zhengdong Wu
Original Assignee
Merck Patent Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh. filed Critical Merck Patent Gmbh.
Publication of HUP0104520A2 publication Critical patent/HUP0104520A2/hu
Publication of HUP0104520A3 publication Critical patent/HUP0104520A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A tal lm ny (I) ltal nos képletű vegyületekre és azok gyógy szatilagelfogadható sóira és szolv tjaira vonatkozik ahol a szubsztituensekfőbb jelentései a k"vetkezők: R jelentése H vagy NO2, R1 jelentésejelentése telített, részben vagy teljesen telítetlen mono-, bi- vagytriciklusos heterociklusos csoport, amelynek 5-13 gyűrűtagja van,amelyben 1 vagy 2 N és/vagy 1 vagy 2 S vagy O atom lehet jelen; Arjelentése fenilcsoport, bifenilcsoport, stilbilcsoport,piridilcsoport, pirimidilcsoport, kinolilcsoport, 1-imidazolilcsoport,pirazolilcsoport, indanilcsoport, dibenzo-furanilcsoport, 9-H-karbazolilcsoport, antracenilcsoport, naftalenilcsoport vagyfluorenilcsoport. A tal lm ny szerinti vegyületek mint adhéziósreceptorantagonist k hatnak, és felhaszn lhatók trombotikusrendellenességek és azokból sz rmazó utók"vetkezmények megelőzésére ésgyógyít s ra. A tal lm ny kiterjed az (I) ltal nos képletűvegyületeket tartalmazó gyógy szati készítményekre és a vegyületek előllít s ra is. Ó
HU0104520A 1998-11-25 1999-11-09 Substituted benzo[de]isoquinoline-1,3-diones process for their preparation and pharmaceutical compositions containing them HUP0104520A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19941398A 1998-11-25 1998-11-25
US39878399A 1999-09-20 1999-09-20
PCT/EP1999/008561 WO2000032577A2 (en) 1998-11-25 1999-11-09 Substituted benzo[de]isoquinoline-1,3-diones

Publications (2)

Publication Number Publication Date
HUP0104520A2 true HUP0104520A2 (hu) 2002-04-29
HUP0104520A3 HUP0104520A3 (en) 2002-10-28

Family

ID=26894745

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104520A HUP0104520A3 (en) 1998-11-25 1999-11-09 Substituted benzo[de]isoquinoline-1,3-diones process for their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
EP (1) EP1144381A2 (hu)
JP (1) JP2002537225A (hu)
KR (1) KR20010080569A (hu)
CN (1) CN1330638A (hu)
AU (1) AU760136B2 (hu)
BR (1) BR9915648A (hu)
CA (1) CA2352045A1 (hu)
CZ (1) CZ20011782A3 (hu)
HU (1) HUP0104520A3 (hu)
ID (1) ID28982A (hu)
NO (1) NO20012544L (hu)
PL (1) PL348204A1 (hu)
SK (1) SK7022001A3 (hu)
TW (1) TW473474B (hu)
WO (1) WO2000032577A2 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429212B1 (en) * 1996-08-16 2002-08-06 Ishihara Sangyo Kaisha Ltd. Medicinal composition
EP1088821A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives
WO2003007931A1 (fr) * 2001-06-08 2003-01-30 Institute Of Medicinal Molecular Design. Inc. Derives de sulfonamide
US6693198B2 (en) * 2002-04-22 2004-02-17 Xanthus Life Sciences, Inc. Amonafide salts
US8097725B2 (en) 2004-12-03 2012-01-17 Roche Diagnostics Operations, Inc. Luminescent indicator dye and optical sensor
FR2915685A1 (fr) * 2007-05-02 2008-11-07 Thales Sa Compose fluorescent a l'etat solide dans l'eau,procede de synthese et utilisation dans des capteurs
EP2970227B1 (en) 2013-03-15 2018-01-10 Alumend, LLC Compositions and methods of using the compositions for plaque softening
US9662324B2 (en) 2013-05-01 2017-05-30 Academia Sinica Methods and compositions for treating β-thalassemia and sickle cell disease
CN103450176B (zh) * 2013-08-15 2016-07-06 大连理工大学 一类含2-（4-氨基苯基）苯并噻唑萘酰亚胺化合物及其应用
US20170283408A1 (en) * 2014-09-19 2017-10-05 Yen-Ta Lu Benzo-heterocyclic compounds and their applications
CN106905237B (zh) * 2017-02-08 2019-05-14 上海师范大学 一种pH和乏氧双响应定位肿瘤细胞的萘酰亚胺类比率荧光探针及其合成方法
CN110283123B (zh) * 2019-07-08 2022-06-17 桂林医学院 4-对甲苯磺酰基哌嗪-3-硝基-1,8-萘酰亚胺衍生物及其合成方法和应用
CN110272388B (zh) * 2019-07-08 2022-06-17 桂林医学院 4-二硫代甲酸哌嗪-3-硝基-1,8-萘酰亚胺衍生物及其合成方法和应用
CN110407865B (zh) * 2019-08-02 2022-04-15 山东师范大学 基于苯磺酰胺结构的式（i）化合物及其制备方法与应用
CN111518075B (zh) * 2020-04-17 2023-03-28 西南大学 萘酰亚胺哌嗪三唑类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2423546C2 (de) * 1974-05-15 1983-01-27 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 4-Amino-1,8- naphthalsäure-N-arylimid-Verbindungen
ES459497A1 (es) * 1977-06-04 1978-04-16 Made Labor Sa Un metodo para la preparacion industrial de naftalimidas y sus derivados.
DE3635711A1 (de) * 1986-10-21 1988-04-28 Knoll Ag 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
JP2001503397A (ja) * 1996-10-21 2001-03-13 アレリックス バイオファーマシューティカルズ インコーポレイテッド ニューロトロフィンアンタゴニスト組成物
WO1998018764A1 (de) * 1996-10-28 1998-05-07 Merck Patent Gmbh Dihydrobenzoanthracenone, -pyrimidinone oder dihydronaphthochinolinone

Also Published As

Publication number Publication date
ID28982A (id) 2001-07-19
CA2352045A1 (en) 2000-06-08
HUP0104520A3 (en) 2002-10-28
KR20010080569A (ko) 2001-08-22
NO20012544D0 (no) 2001-05-23
AU2660300A (en) 2000-06-19
TW473474B (en) 2002-01-21
SK7022001A3 (en) 2002-09-10
EP1144381A2 (en) 2001-10-17
PL348204A1 (en) 2002-05-06
WO2000032577A3 (en) 2000-09-21
NO20012544L (no) 2001-05-23
WO2000032577A2 (en) 2000-06-08
BR9915648A (pt) 2001-08-14
CN1330638A (zh) 2002-01-09
CZ20011782A3 (cs) 2001-09-12
AU760136B2 (en) 2003-05-08
JP2002537225A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
HUP0104520A2 (hu) Szubsztituált benzo[de]izokinolin-1,3-dion-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények
NO308772B1 (no) Sublingual eller buckal farmasoytisk blanding inneholdende trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-c]pyrrol, samt anvendelse av forbindelsen for fremstilling av farmasoytisk blanding
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
CA2293823A1 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
ES8204739A1 (es) Un procedimiento para preparar compuestos de cefem
AP9801237A0 (en) Quinoline derivatives.
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
HUP0102084A2 (hu) Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
JO1351B1 (en) Chemical compounds
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO810684L (no) Fremgangsmaate ved fremstilling av indanderivater.
ES8103072A1 (es) Procedimiento para preparar nuevos compuestos de tiadiazoli-lo
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
CA2286511A1 (en) Novel macrolide derivatives
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
HUP0104469A2 (hu) Szubsztituált benzo[de]izokinolin-1,3-dion-származékok, eljárás a vegyületek előállítására és ezeket tartalmazó gyógyszerkészítmények
HUP9602868A2 (hu) Új 1,7,7-trimetil-biciklo[2.2.1]heptán-származékok
GB1256750A (hu)
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
ES8307224A1 (es) Un metodo para preparar derivados de pirazolina.
AP9801235A0 (en) Erythromycin derivatives.
HUP0203045A2 (hu) Epesavval képezett 4-benzil-amino-kinolin konjugátumok és hetero-analógjai, valamint eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények, és ezek alkalmazása
ES8303418A1 (es) Un procedimiento para la preparacion de derivados de benzo (4,5 pinano 2,3c) pirrol.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.